Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy

Academic Radiology(2022)10.1016/j.acra.2022.02.008Source: DataRank Database

Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy is a research paper published in Academic Radiology (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 1.04)OA: closedTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Federico Pineda ORCID,Frederick M. Howard ORCID,Elle Hill ORCID,Teodora Szasz ORCID,Rabia Safi

Live enrichment

PubMed:35351365 OpenAlex:https://openalex.org/W4221084573

National Institutes of Health

Grant: 1F32 CA265232

National Institutes of Health

Grant: 1U24 CA226110

National Institutes of Health

Grant: R01 CA172801

National Institutes of Health

Grant: U01 CA142565

Cancer Prevention and Research Institute of Texas

Grant: RP160005

NCI NIH HHS

Grant: F32 CA265232

NCI NIH HHS

Grant: P20 CA233307

NCI NIH HHS

Grant: P30 CA014599

NCI NIH HHS

Grant: R01 CA133490

NCI NIH HHS

Grant: R01 CA167785

NCI NIH HHS

Grant: P50 CA125183

NCI NIH HHS

Grant: R01 CA078803

NCI NIH HHS

Grant: U24 CA226110

National Cancer Institute

Segal Family Foundation

University of Chicago

FWCI

1.04

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1076633222001180?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1076633222001180?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.acra.2022.02.008

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35351365

Fields of Study

MRI in cancer diagnosisBreast Cancer Treatment StudiesBreast Lesions and CarcinomasBreastBreast NeoplasmsContrast MediaFemaleHumansKineticsMagnetic Resonance ImagingNeoadjuvant TherapyRetrospective Studies

MeSH Terms

BreastBreast NeoplasmsContrast MediaFemaleHumansKineticsMagnetic Resonance ImagingRetrospective StudiesNeoadjuvant Therapy

Keywords

ParenchymaMedicineBreast cancerMagnetic resonance imagingNuclear medicineNeoadjuvant therapyCancerPathologyRadiologyInternal medicineBilateral asymmetryBreast Cancer ImagingBackground Parenchymal Enhancement (Bpe)Background Parenchymal KineticsUltrafast Dynamic Contrast Enhanced Mri (Dce-mri)

Sustainable Development Goals

SDG 0: Good health and well-being

Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy

FAIR Checklist

Authors (11)

Funding (16 grants)

Impact

Open Access

Topics